Trial NCT00625898

View at ClinicalTrials.gov 
Org. Study IDs: NSABP B-44-I
Secondary IDs: BETH CIRG (TRIO) 011 Roche BO20906

Last trial update was posted on 2020-09-10

MeSH Interventions

Bevacizumab Carboplatin Cyclophosphamide Docetaxel Epirubicin Fluorouracil Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID